Evaluating amide proton transfer imaging for improved glioma assessment: implications for RANO 2.0 criteria
British Journal of Radiology · 2025
DOI: 10.1093/bjr/tqaf115 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Hua-Zhen Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, Shenzhen, 51…. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Magnetic Resonance Imaging. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Guangdong Medical Science and Technology Research Fund, Clinical Research Project, China.
Abstract (Originalsprache)
Objectives
The updated RANO 2.0 criteria acknowledge the limitations of conventional MRI in distinguishing tumour progression (TP) from pseudoprogression (PsP) after surgery. Advanced imaging techniques, such as amide proton transfer (APT) imaging, further validating its integration into the RANO 2.0 framework to enhance assessment accuracy.
Methods
This study retrospectively analysed 75 patients with high-grade gliomas who underwent MRI, including APT imaging. APT imaging was assessed for its ability to differentiate true tumour recurrence from PsP, using various regions of interest (ROIs) to analyse APT signal variations.
Results
APT imaging significantly improved the diagnostic accuracy in distinguishing glioma TP from PsP when compared to conventional MRI alone. Metrics such as APTmax and APTmean demonstrated higher sensitivity and specificity compared to APTmin, validating the integration of APT imaging into the RANO 2.0 criteria by providing valuable insights into tumour metabolism and the microenvironment.
Conclusions
APT imaging is a valuable addition to conventional MRI for postoperative glioma evaluation. supporting its integration into the RANO 2.0 criteria for a more accurate assessment of tumour status and potentially guiding better patient management. Further research is needed to confirm these findings and establish clinical protocols. Advances in knowledge This study highlights the potential of APT imaging in enhancing the diagnostic accuracy for distinguishing TP from PsP, demonstrates that APT imaging, particularly when integrated with multimodal MRI (T1WI, T2WI, T2-FLAIR, and contrast-enhanced T1WI), improves the sensitivity and specificity of diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, Shenzhen, 518000, China.
- Shantou University Medical College, Shantou 515041, 243 Daxue Road, Shantou City, Guangdong Province, Shantou, 515041, China.
- Philips Healthcare, Guangzhou, China International Center, Yuexiu District, Guangzhou, Yuexiu District, 510000, China.
ORCID-Profile: Hua-Zhen Deng, Fan Lin
Förderung
- Guangdong Medical Science and Technology Research Fund
- Clinical Research Project, China
Zitieren
APA
Deng, H. Z., Liu, G. L., Fan, W. J., Hua, X., Yilihamu, Y., Xu, Y. Z., Zhang, H. W., Liu, X. L., & Lin, F. (2025). Evaluating amide proton transfer imaging for improved glioma assessment: implications for RANO 2.0 criteria. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf115
Vancouver
Deng HZ, Liu GL, Fan WJ, Hua X, Yilihamu Y, Xu YZ, et al. Evaluating amide proton transfer imaging for improved glioma assessment: implications for RANO 2.0 criteria. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf115
BibTeX
@article{Deng2025,
author = {Deng, Hua-Zhen and Liu, Gui-Liang and Fan, Wen-Jing and Hua, Xue and Yilihamu, Yilinuer and Xu, Yong-Zhou and Zhang, Han-Wen and Liu, Xiao-Lei and Lin, Fan},
title = {Evaluating amide proton transfer imaging for improved glioma assessment: implications for RANO 2.0 criteria},
journal = {British Journal of Radiology},
year = {2025},
doi = {10.1093/bjr/tqaf115}
}
EUVIMED